Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Regeneron Pharmaceuticals (REGN) Q3 2021 Earnings
REGN
+2.02%
5
Aug
Confirmed
Q4 2020
Q1 2021
Q2 2021
Q3 2021
7.32
13.48
19.64
25.8
Details
Expected EPS
18.83
Actual EPS
25.8
Surprise EPS
6.97
Surprise Percent
+37.02%
Description
Regeneron Pharmaceuticals (REGN) has reported earnings of 25.8 per share for Q3 2021.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login